Comparison Chart Unicycive Therapeutics, Inc.

Stocks

UNCY

US90466Y2028

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2026-10-09 EDT			5-day change	1st Jan Change
4.110 ^USD	+0.98%		-2.61%	-28.77%

10-01	Unicycive Therapeutics, Inc. Appoints Meredith Manning to its Board of Directors, Each of the Audit, Compensation, and Nominating and Corporate Governance Committees, and Chairperson of the Nominating and Corporate Governance Committee	CI
09-29	Unicycive Therapeutics Announces Resubmission of New Drug Application for Oxylanthanum Carbonate	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	UNICYCIVE THERAPEUTICS, INC.	Bio Therapeutic Drugs	+0.98%	-2.61%	-28.77%	-7.43%	-84.72%	114M